产品: 磷酸化 TMEM173/STING (Ser366) 抗体
货号: AF7416
描述: Rabbit polyclonal antibody to Phospho-TMEM173/STING (Ser366)
应用: WB IHC IF/ICC
文献验证: WB, IF/ICC
反应: Human, Mouse, Rat
预测: Pig, Bovine, Horse, Sheep, Rabbit
蛋白号: Q86WV6
RRID: AB_2843856

浏览相似产品>>

   规格 价格 库存
 100ul RMB¥ 2800 现货
 200ul RMB¥ 3800 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user. For optimal experimental results, antibody reuse is not recommended.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Mouse, Rat
克隆:
Polyclonal
特异性:
Phospho-TMEM173/STING (Ser366) Antibody detects endogenous levels of TMEM173/STING only when phosphorylated at Ser366.
RRID:
AB_2843856
引用格式: Affinity Biosciences Cat# AF7416, RRID:AB_2843856.
偶联:
Unconjugated.
纯化:
The antibody is from purified rabbit serum by affinity purification via sequential chromatography on phospho-peptide and non-phospho-peptide affinity columns.
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

endoplasmic reticulum IFN stimulator; Endoplasmic reticulum interferon stimulator; ERIS; FLJ38577; hMITA; hSTING; Mediator of IRF3 activation; MITA; Mitochondrial mediator of IRF3 activation; MPYS; N terminal methionine proline tyrosine serine plasma membrane tetraspanner; NET23; Stimulator of interferon genes; Stimulator of interferon genes protein; STING; TM173_HUMAN; Tmem173; Transmembrane protein 173;

抗原和靶标

免疫原:

A synthesized peptide derived from human TMEM173/STING around the phosphorylation site of Ser366.

基因/基因ID:

研究领域

· Organismal Systems > Immune system > NOD-like receptor signaling pathway.   (View pathway)

· Organismal Systems > Immune system > RIG-I-like receptor signaling pathway.   (View pathway)

· Organismal Systems > Immune system > Cytosolic DNA-sensing pathway.   (View pathway)

文献引用

1). Polydopamine as a biocompatible and precise mitochondrial targeted therapeutic platform for reversing myocardial ischemia-reperfusion injury. Bioactive Materials, 2025 [IF=20.3]

Application: WB    Species: Rat    Sample: H9C2 cells

Fig. 5. CPC inhibits cGAS-STING pathway activation. (A) Mechanism of CPC inhibiting the activation of cGAS-STING signaling pathway. (B) Immunofluorescence staining and colocalization quantification of DAPI/TOM20/dsDNA in H9C2 cells from different treatment groups. Cytoplasmic dsDNA is indicated by yellow arrow, scale bar: 20 μm. (C) Quantitative real-time PCR analysis of mtDNA: mtDNA content was normalized to nuclear DNA. (D) Determination of the level of cGAMP in H9C2 cells. (E–I) WB of cGAS-STING pathway-related proteins in H9C2 cells, including representative images and quantitative analysis of cGAS, P-STING/STING, P-NF-κB/NF-κB and P-IRF3/IRF3. (J) Determination of the level of IL-1β in H9C2 cells. (K) Determination of the level of IL-6 in H9C2 cells. (L) Immunofluorescence staining of DAPI/TOM20/dsDNA in heart tissue from different treatment groups, the cytoplasmic dsDNA is indicated by yellow arrow, scale bar: 20 μm and 10 μm. (M) The colocalization analysis of DAPI/TOM20/dsDNA in heart tissues: the intensity profiles of the fluorescence signals. (N) Representative images of cGAS and P-STING immunohistochemical staining in heart tissues of different treatment groups, scale bar: 50 μm. Data were expressed as mean ± SE. Statistical significance was performed by one-way ANOVA with Tukey post hoc test. (n = 3, ns: P > 0.05, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001).

2). Near-infrared light-induced photothermal and immunotherapy system for lung cancer bone metastasis treatment with simultaneous bone repair. Bioactive materials, 2025 (PubMed: 40538765) [IF=18.9]

3). Inhibiting Chemotherapy Immune Tolerance and Reversing Tumor Microenvironment by Macrophage-Targeted Nanohybrid Systems for Enhancing Tumor Chemo-Immunotherapy. ADVANCED FUNCTIONAL MATERIALS, 2025 [IF=18.5]

4). Nanosensitizer for enhanced radiotherapy via tumor microenvironment reshaping and ROS amplification. Theranostics, 2025 [IF=13.3]

5). PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer. Cancer research, 2023 (PubMed: 36512628) [IF=12.5]

6). Manganese-doped liquid metal nanoplatforms for cellular uptake and glutathione depletion-enhanced photothermal and chemodynamic combination tumor therapy. Acta biomaterialia, 2025 (PubMed: 39522626) [IF=9.7]

7). Microglial double stranded DNA accumulation induced by DNase II deficiency drives neuroinflammation and neurodegeneration. Journal of neuroinflammation, 2025 (PubMed: 39833906) [IF=9.3]

8). Loss of Nrf2 aggravates ionizing radiation-induced intestinal injury by activating the cGAS/STING pathway via Pirin. Cancer letters, 2024 (PubMed: 39233044) [IF=9.1]

9). STING orchestrates microglia polarization via interaction with LC3 in autophagy after ischemia. Cell death & disease, 2024 (PubMed: 39537618) [IF=9.0]

10). Novel intravenous formulation for radiosensitization in osteosarcoma treatment. Materials today. Bio, 2025 (PubMed: 40206141) [IF=8.7]

Application: WB    Species: Mouse    Sample: K7M2 cells

Fig. 5. HPTM with NIR and RT induced accumulation of cytosolic DNA, activation of cGAS-STING and ICD. (A) Representative fluorescence images and (B) quantitative analysis of Picogreen(green) staining of K7M2 cells treated by different treatments, including HPTM, HP + NIR + RT, RT, HPTM + NIR, HPTM + RT, HPTM + NIR + RT. (C) Activation of cGAS-STING related protein was measured by Western Blot. (D) Cytokine levels of IFN-γ in K7M2 cells by ELISA on day 3 post various treatments. (E) Released ATP and (F) HMGB1 were quantified through ATP detection kits and ELISA kits, respectively. (G) Calreticulin immunofluorescence on the outer surface of K7M2RR cells was imaged by LSCM. All experiments were carried out with 3 biological replicates. # indicates a group which was compared with other groups. All values are the mean ± SD, n = 3. P values, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001,∗∗∗∗p < 0.0001. ns, not significant.

加载更多

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.